Iron status influences mitochondrial disease progression in Complex I-deficient mice

Area of Science:

• Biochemistry
• Neuroscience
• Genetics

Background:

• Mitochondrial dysfunction, particularly Complex I defects, is implicated in genetic and age-related diseases.
• Mice lacking the NDUFS4 subunit of Complex I serve as a model for severe mitochondrial disease, mimicking Leigh Syndrome symptoms.
• Complex I's structure suggests a potential link between its deficiency and iron dysregulation.

Purpose of the Study:

• To investigate whether Complex I deficiency leads to iron perturbations and if these impact disease progression.
• To determine the therapeutic potential of iron modulation in NDUFS4 knockout mice.

Main Methods:

• Utilized NDUFS4 knockout mice as a model for mitochondrial disease.
• Administered iron supplementation and iron restriction diets to assess their effects on disease symptoms.
• Analyzed markers of brain degeneration, neuroinflammation, iron metabolism (hepcidin, iron-responsive proteins), and survival.

Main Results:

• Iron supplementation accelerated brain degeneration and mortality in NDUFS4 knockout mice.
• Iron restriction delayed disease onset, reduced neuroinflammation, and increased survival.
• NDUFS4 knockout mice exhibited signs of liver iron overload, which were ameliorated by iron restriction.

Conclusions:

• Perturbed iron homeostasis, specifically iron overload, contributes to the pathology observed in NDUFS4-deficient mice.
• Iron dysregulation may be a key factor in the progression of Leigh Syndrome and other mitochondrial disorders.
• Iron restriction presents a potential therapeutic strategy for mitigating mitochondrial disease progression.